NCT07063147Recruiting
TTE Improves Clinical Management of Stable Chest Pain
Improving the Clinical Management of Stable Chest Pain Based on Imaging: a Registry of Transthorcic Echocardiography
Source: ClinicalTrials.gov · Last updated 18 Jul 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The investigator aims to prospectively enroll patients who were referred for transthorcic echocardiography (TTE) for the assessment of stable chest pain (SCP) suspected of obstructive coronary artery disease (CAD). All patients underwent TTE according to established guidelines and local institutional protocols. This study will determine if TTE-based imaging evaluation can provide more informaton to improve clinical management for SCP, including fewer MACE and better decision-making of downstream investigations and therapeutic interventions.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 50000 (estimated)
- First submitted
- 3 Jul 2025
- Start date
- 1 Jan 2025
- Primary completion date
- 31 Dec 2030
- Lead sponsor
- Tianjin Chest Hospital
- Diseases
- Coronary artery disease
- NCT number
- NCT07063147
What you commit to
- Study type: Observational
- Planned participants: 50000
- From 1 Jan 2025 to the primary completion date, 31 Dec 2030
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- previous CAD or coronary revascularization
Other illness
- acute coronary syndromes
- cardiomyopathy, valvular disease, congenital heart disease or left cardiac insufficiency because of other reasons
Other
- nonsinus rhythm
Who the study is looking for
- symptomatic patients with SCP suspected of obstructive CAD.
- referred for TTE for the assessment of SCP.
- ≥18 years of age.
- signed informed consent.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Tianjin Chest Hospital Coordinator of this site? Confirm its status | Tianjin | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.